| Income taxes |
11. Income taxes The following table summarizes the income taxes recognized in profit or loss for the years ended December 31, 2024, 2023 and 2022. | | | | | | | | | | | | Year ended December 31, | | | 2024 | | 2023 | | 2022 | | | | (Euro, in thousands) | Current tax | | € | (1,301) | | € | (5,928) | | € | (1,738) | Deferred tax | | | 3,104 | | | (3,685) | | | 1,166 | Income taxes | | € | 1,803 | | € | (9,613) | | € | (572) |
Current tax, consisting of corporate income taxes, and deferred tax income/cost (–) related to subsidiaries of our continuing operations working on a cost plus basis. The decrease in 2024 as compared to 2023 was primarily due to the re-assessment in 2023 of net deferred tax liabilities and corporate income tax payables as a result of a one-off intercompany transaction. TAXES RECOGNIZED IN PROFIT OR LOSS For the purpose of the disclosure below corporation tax was calculated at 25% (2023 and 2022: 25%)—which is the tax rate applied in Belgium—on the estimated assessable result for the year. The applied tax rate for other territorial jurisdictions was the tax rate that is applicable in these respective territorial jurisdictions on the estimated taxable result of the accounting year. | | | | | | | | | | | | Year ended December 31, | | | 2024 | | 2023 | | 2022 | | | | (Euro, in thousands) | Profit/loss (-) before tax | | € | (3,085) | | € | 5,625 | | € | (70,849) | Income tax debit/credit (-), calculated using the Belgian statutory tax rate on the accounting income/loss (-) before tax (theoretical) | | | (771) | | | 1,406 | | | (17,712) | Tax income (-)/expenses in income statement (effective) | | | (1,803) | | | 9,613 | | | 572 | Difference in tax expense/income to explain | | € | (1,032) | | € | 8,207 | | € | 18,284 | | | | | | | | | | | Effect of tax rates in other jurisdictions | | € | (132) | | € | (94) | | € | (337) | Effect of non-taxable income | | | (5,247) | | | (6,752) | | | (5,828) | Effect of share based payment expenses without tax impact | | | 4,399 | | | 9,157 | | | 15,501 | Effect of expenses/income (-) not subject to tax | | | 52 | | | (5) | | | (146) | Effect of non tax-deductible expenses | | | 1,117 | | | 1,549 | | | 2,975 | Effect of recognition of previously non-recognized deferred tax assets | | | 15 | | | (81) | | | (1,677) | Effect of tax losses (utilized) reversed | | | — | | | (267) | | | — | Effect of under or over provision in prior periods | | | 13 | | | (722) | | | 1,101 | Effect of non-recognition of deferred tax assets | | | (1,338) | | | 34,339 | | | 4,819 | Effect of derecognition of previously recognized deferred tax assets | | | 89 | | | 1,062 | | | 1,877 | Effect of use of innovation income deduction | | | — | | | (29,979) | | | — | Total explanations | | € | (1,032) | | € | 8,207 | | € | 18,284 |
Non-taxable income for the years ended December 31, 2024, 2023 and 2022 related to non-taxable grants and tax credits. |